Axon Enterprise (NASDAQ: AXON) reported second-quarter FY26 revenue of $904 million, a 35% year-over-year increase. The public safety technology firm raised its full-year revenue guidance to 32-34% growth, citing strong bookings across international and federal markets.

Financial Performance

Revenue growth was broad-based, with software and services revenue rising 36% to $398 million. Connected devices revenue grew 35% to $507 million, driven by Dedrone counter-drone solutions, Taser 10, and Axon Body 4. Platform Solutions revenue surged 123% to $150 million.

Adjusted gross margin expanded 130 basis points sequentially to 62.9%, primarily due to tariff refunds. Adjusted EBITDA reached $242 million, or a 26.8% margin. Operating cash flow improved to an inflow of $20 million from an outflow of $92 million in the prior year.

What the Numbers Show

The divergence between top-line growth and cash flow dynamics highlights significant working capital investment. While operating cash flow turned positive, free cash flow remained slightly negative at an outflow of $1 million. This indicates that despite strong operational cash generation, the company is deploying substantial capital into inventory to support customer demand and mitigate supply chain risks, as noted by management.

Bookings and Outlook

Gross bookings grew 20% in Q2, building on nearly 50% growth in the prior year quarter. On a five-year normalized basis, bookings grew over 30%. Future contracted bookings rose more than 40% to $15.1 billion. Management expects full-year adjusted EBITDA margin of approximately 25.5%, noting that memory component costs will impact Q3 margins before scaling back in Q4.

Axon Enterprise (NASDAQ: AXON) has generated an average annual return of 22.55% over the past five years, outperforming the broader market by 11.14% on an annualized basis.

The company currently holds a market capitalization of $39.82 billion. Historical performance data indicates that a hypothetical investment of $1,000 in the stock five years ago would have grown to $2,780.14 today, based on a share price of $490.21 at the time of writing.

Performance Metrics

What the Numbers Show

The divergence between the stock’s absolute return and its relative outperformance highlights the baseline market conditions during this period. With Axon delivering a 22.55% annualized return while beating the market by 11.14%, the implied average annual market return was approximately 11.41%. This suggests that while the broader market provided positive growth, Axon’s operational execution or valuation expansion drove returns nearly double the benchmark index over the same timeframe.